Leiden

• Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Subcutaneously in Children With Generalized Myasthenia Gravis (AD … Recruiting
  2023-507379-23-00 10 2022-08-18 Generalized Myasthenia Gravis
• Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels (ADAPT ALEC) Recruiting
  2023-506886-76-00 6 2022-03-23 ALK positive non-small cell lung cancer
• Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with P … Recruiting
  2024-514617-35-00 4 2021-12-20 Progressive forms of Multiple Sclerosis
• Study of efficacy and safety of iptacopan in complement 3 glomerulopathy patients Recruiting
  2023-509331-83-00 5 2021-07-28 complement 3 glomerulopathy
• Phase I/II clinical trial of autologous hematopoietic stem cell gene therapy in rag1-deficient severe combined immunodeficiency Recruiting
  2023-510204-50-00 3 2021-07-23 Severe combined immunodeficiency based on genetic defect in the Recomb
• A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma. Recruiting
  2023-505261-84-00 5 2020-10-06 Primary high risk leiomyosarcoma or liposarcoma of retroperitoneal spa
• Stem cell transplantation in diffuse cutaneous systemic sclerosis: upfront therapy or rescue therapy after failure of immunosuppressants Recruiting
  2023-505877-34-00 6 2020-08-18 Diffuse cutaneous systemic sclerosis according to the ACR/EULAR criter
• SAR447971 first-in-human study Recruiting
  2026-525333-22-00 1 2026-05-22 Hidradenitis
• Effect of NBI-921355 on corticospinal excitability in healthy participants Recruiting
  2025-524134-26-00 3 2026-05-08 Epilepsy
• A first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune medi … Recruiting
  2026-525575-22-00 1 2026-05-07 Psoriasis
• Clinical Surveillance vs. Anticoagulation for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism: A Multicenter Randomized Plac … Recruiting
  2023-507801-32-00 6 2026-04-22 Isolated Subsegmental Pulmonary Embolism
• An investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by corona … Recruiting
  2024-514874-36-01 4 2026-04-17 Refractory angina due to obstructive coronary artery disease
• A Phase 3 Study to Evaluate AOC 1020 in Participants with FSHD Recruiting
  2025-521012-18-00 5 2026-04-13 Facioscapulohumeral Muscular Dystrophy (FSHD)
• PHASE 1 STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF E-VIM VACCINE CVX1 WITH OR WITHOUT ICI IN THE TREATMENT OF SUBJECTS … Recruiting
  2025-523781-25-00 1 2026-04-02 metastatic solid cancer, muscle invasive bladder cancer, localized or
• CSX-1004 Effects on Fentanyl-Induced Respiratory Depression Recruiting
  2025-524133-33-00 4 2026-03-27 Opioid use disorder
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting
  2025-522674-36-00 5 2026-03-24 Metabolic Dysfunction-Associated Steatotic Liver Disease
• BE-MOBILYZED: BElimumab to MOBIlise memory B-cells from secondary LYmhoid organs to improve memory B-cell HLA-specificity profiling to suppo … Recruiting
  2023-508116-32-00 4 2026-03-17 Antibody-mediated rejection of renal grafts
• A trial to assess the efficacy and safety of ACT-1004-1239 in adults with progressive multiple sclerosis Recruiting
  2025-522922-11-00 4 2026-03-03 Progressive multiple sclerosis (MS)
• A study of the safety, tolerability, pharmacokinetics and preliminary efficacy of TNV108 in healthy adults and patients with diabetic periph … Recruiting
  2025-524258-32-00 1 2026-03-02 Diabetic Peripheral Neuropathy (DPN)
• The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi … Recruiting
  2024-512040-28-01 6 2026-03-01 Confirmed diagnosis of Alcoholic liver cirrhosis
• A Phase 1 Study of Fentanyl Vaccine Recruiting
  2025-524277-16-00 7 2026-02-26 Opioid induced respiratory depression
• A Study to Assess Adverse Events, Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Ad … Recruiting
  2025-521124-29-00 10 2026-02-13 Non-Small Cell Lung Cancer
• Single and multiple ascending dose of ZP9830 in healthy participants Recruiting
  2023-509929-51-00 1 2026-02-10 Autoimmune diseases
• A study on the safety, tolerability, and effectiveness of the new drug LAD106 in healthy volunteers. Recruiting
  2025-523328-31-00 1 2026-02-06 Inflammatory diseases

Showing 73–96 of 450 trials